A substance being studied in the treatment of some types of cancer. Nimotuzumab binds to a protein called epidermal growth factor receptor (EGFR), which is found on some normal cells and some types of cancer cells. Blocking this protein may help keep cancer cells from growing. Nimotuzumab is a type of monoclonal antibody. Also called Theraloc.
( ny-moh-TOO-zoo-mab )
Source: NCI Dictionary of Cancer Terms
Search the Glossary of Medical Terms
Newsletter
Sign up for the QuackTrack.org newsletter below!